Sign in →

Test ID: ACASM Pernicious Anemia Cascade, Serum

Reporting Name

Pernicious Anemia Cascade

Useful For

Diagnosis of pernicious anemia

 

Diagnosis of vitamin B12 deficiency-associated neuropathy

Clinical Information

Vitamin B12 deficiency can be caused by many factors, one of which is pernicious anemia, a condition resulting in deficient production of intrinsic factor in the parietal cells of the stomach. Intrinsic factor is a protein that is needed to assist in the absorption of vitamin B12 into the small intestine. Vitamin B12 is converted into adenosylcobalamin, which converts L-methylmalonic acid to succinyl coenzyme A; hence, a decrease in vitamin B12 absorption in the intestine can cause an excess of methylmalonic acid within the body.

 

Vitamin B12 deficiency may present with any combination of the following: macrocytic anemia, glossitis (painful inflammation of the tongue), peripheral neuropathy, weakness, hyperreflexia, ataxia, loss of proprioception, poor coordination, and affective behavioral changes. These manifestations may occur in any combination; many patients present with neurologic symptoms without macrocytic anemia.

 

A group of tests is often required to establish the correct diagnosis as determination of vitamin B12 in serum does not detect all cases of vitamin B12 deficiency. Mayo Clinic's Department of Laboratory Medicine and Pathology offers a diagnostic algorithm to expedite the identification of patients with vitamin B12 deficiency. This algorithm takes into account the following facts:

-The most sensitive test for vitamin B12 deficiency at the cellular level is the assay for methylmalonic acid (MMA).

-Nearly half of the cases of pernicious anemia can be unambiguously identified if the serum test for intrinsic factor blocking antibody is positive (this is a simpler and less expensive test than the MMA).

-Serum gastrin is usually markedly increased in pernicious anemia (as a result of gastric atrophy) and this test can be used as a substitute for the more complicated and more expensive Schilling test of intestinal absorption of vitamin B12.

 

The algorithm is similar to that published by Green,(1) except that the serum gastrin assay is performed in place of the Schilling test. Experience with both Mayo Clinic and Mayo Clinic Laboratories' cases has corroborated that this is a cost-effective alternative to the Schilling test.

 

In our experience, greater than 90% of laboratory test costs can be saved by using the algorithm rather than ordering all of the services for a patient suspected of having B12 deficiency. Furthermore, the substitution of the serum gastrin assay for the Schilling test offers 3 advantages:

1. It is an in vitro test that does not require administration of radioisotopes to patients

2. It can be performed on mailed-in specimens

3. It is much less expensive

 

Only those tests that are appropriate, as defined by the algorithm, will be performed.

Interpretation

Vitamin B12 >400 ng/L

Results do not suggest B12 deficiency-no further testing.

Vitamin B12 150 to 400 ng/L

Borderline vitamin B12 level-methylmalonic acid (MMA) is performed. If MMA is >0.40 nmol/mL, then intrinsic factor blocking antibody (IFBA) is performed.

Vitamin B12 <150 ng/L

Vitamin B12 deficiency-IFBA is performed. If IFBA is negative or indeterminate, then gastrin is performed.

MMA ≤0.40 nmol/mL

This value implies that there is no vitamin B12 deficiency at the cellular level.

IFBA positive

Consistent with pernicious anemia, Graves disease, or Hashimoto thyroiditis.

Gastrin >200 pg/mL

Result consistent with pernicious anemia.

Gastrin <200 pg/mL

Result does not suggest pernicious anemia.

 

See Vitamin B12 Deficiency Evaluation in Special Instructions.

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
IFBPA Intrinsic Factor Blocking Ab, S Yes, (order IFBA) No
MMAPA Methylmalonic Acid, QN, S Yes, (order MMAS) No
GASTR Gastrin, S Yes, (order GAST) No

Testing Algorithm

If vitamin B12 is less than 150 ng/L, then intrinsic factor blocking antibody (IFBA) is performed. If IFBA is negative or indeterminate, then gastrin is performed.

If vitamin B12 is 150 to 400 ng/L, then methylmalonic acid (MMA) is performed. If MMA is greater than 0.40 nmol/mL, then IFBA is performed.

 

See Vitamin B12 Deficiency Evaluation in Special Instructions.

Analytic Time

Same day/1 day

Day(s) and Time(s) Performed

Monday through Friday; 6 a.m.-12 a.m.

Saturday; 6 a.m.-6 p.m.

Clinical Reference

1. Green R, Kinsella LJ: Current concepts in the diagnosis of cobalamin deficiency. Neurology. 1995;45:1435-1440

2. Lahner E, Annibale B: Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009 Nov 7;15(41):5121-5128

3. Bizzaro N, Antico A. Diagnosis and classification of pernicious anemia. Autoimmun Rev. 2014;13(4-5):565-568

4. Toh BH. Pathophysiology and laboratory diagnosis of pernicious anemia. Immunol Res. 2017;65(1):326-330

Method Name

Immunoenzymatic Assay

Specimen Type

Serum


Specimen Required


Patient Preparation:

1. This test should not be ordered on patients who have received a vitamin B12 injection within the last 2 weeks.

2. Patient should be fasting for 8 hours.

3. If medically feasible, proton pump inhibitor (omeprazole, lansoprazole, dexlansoprazole, esomeprazole, pantoprazole, and rabeprazole) therapy should be discontinued 1 week before measurement of serum gastrin levels.

4. Drugs that interfere with gastrointestinal motility (eg, opioids) should be discontinued for at least 2 weeks before serum gastrin testing.

Container/Tube:

Preferred: Red top

Acceptable: Serum gel

Specimen Volume: 4 mL

Collection Instructions:

1. Divide specimen into 3 plastic vials, 1 containing 1 mL, 1 containing 1.5 mL, and 1 containing 1.5 mL.

2. Band specimens together.


Specimen Minimum Volume

2.3 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Frozen (preferred) 30 days
  Refrigerated  24 hours

Special Instructions

Reference Values

180-914 ng/L

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information

82607-Vitamin B12 assay

82941-Gastrin (if appropriate)

83921-MMA (if appropriate)

86340-IFBA (if appropriate)

LOINC Code Information

Test ID Test Order Name Order LOINC Value
ACASM Pernicious Anemia Cascade 2132-9

 

Result ID Test Result Name Result LOINC Value
B12PA Vitamin B12 Assay, S 2132-9

Forms

If not ordering electronically, complete, print, and send a Benign Hematology Test Request Form (T755) with the specimen.

Mayo Clinic Laboratories | Neurology Catalog Additional Information:

mml-Behavioral, mml-Movement-Disorders, mml-Demyelinating-Diseases, mml-Neuroimmunology, mml-Neuromuscular, mml-Autonomic, mml-Pediatric, mml-Neurometabolic, mml-Neuro-ophthalmology